{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:01:54Z","timestamp":1649160114197},"reference-count":2,"publisher":"BMJ","issue":"6822","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1992,2,1]]},"DOI":"10.1136\/bmj.304.6822.318-b","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T12:16:37Z","timestamp":1238415397000},"page":"318-318","source":"Crossref","is-referenced-by-count":0,"title":["Appropriate chemotherapy for palliating advanced cancer."],"prefix":"10.1136","volume":"304","author":[{"given":"M. S.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"\"43","article-title":"Spseech and survival. Tradeoffs between quality of life in laryngeal cancer. N EnglJ this tragedy by offering the most powerful form of non-surgical treatment as the primary treatment. Fortunately, this message seems to have filtered hog oms rts peils ete, atog patients. M84 protocol","volume":"\"A):\" # \"305:\"","author":"McNeil, B.J.; Weichselbaum, R.; Pauker, S.G.","year":"1988","unstructured":"McNeil BJ, Weichselbaum R, Pauker SG. Spseech and survival. Tradeoffs between quality of life in laryngeal cancer. N EnglJ this tragedy by offering the most powerful form of non-surgical treatment as the primary treatment. Fortunately, this message seems to have filtered hog oms rts peils ete,atog patients. M84 protocol. Cancer Treat Rev 1988;15(suppl A):43-8. Med 1981;305:982-7.","journal-title":"Cancer Treat Rev"},{"key":"ref_2","article-title":"Voice after laryngectomy. BAMJ 1992; 304: 2-3. cyclophosphamide, and melphalan over the well head charges have never been incurred. In Norway, 4 Januar~~~~~~~~.) ~~established melphalan regimen. At four years 31%","author":"Gleeson, M.","unstructured":"Gleeson M. Voice after laryngectomy. BAMJ 1992;304:2-3. cyclophosphamide, and melphalan over the well head charges have never been incurred. In Norway, 4 Januar~~~~~~~~.) ~~established melphalan regimen. At four years 31% Germany, Ireland, the Netherlands, and Spain less"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.304.6822.318-b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:46:18Z","timestamp":1601117178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.304.6822.318-b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2,1]]},"references-count":2,"journal-issue":{"issue":"6822","published-print":{"date-parts":[[1992,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.304.6822.318-b","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2,1]]}}}